Antimicrobial, cytotoxic, and insulin‐releasing activities of the amphibian host‐defense peptide ocellatin‐3N and its L‐lysine‐substituted analogs
Open Access
- 5 December 2022
- journal article
- research article
- Published by Wiley in Journal of Peptide Science
- Vol. 29 (4) , e3463
Abstract
The host‐defense peptide ocellatin‐3N (GIFDVLKNLAKGVITSLAS.NH2), first isolated from the Caribbean frog Leptodactylus nesiotus, inhibited growth of clinically relevant Gram‐positive and Gram‐negative bacteria as well as a strain of the major emerging yeast pathogen Candida parapsilosis. Increasing cationicity while maintaining amphipathicity by the substitution Asp4→Lys increased potency against the microorganisms by between 4‐ and 16‐fold (MIC ≤3 μM) compared with the naturally occurring peptide. The substitution Ala18→Lys and the double substitution Asp4→Lys and Ala18→Lys had less effects on potency. The [D4K] analog also showed 2.5‐ to 4‐fold greater cytotoxic potency against non‐small‐cell lung adenocarcinoma A549 cells, breast adenocarcinoma MDA‐MB‐231 cells, and colorectal adenocarcinoma HT‐29 cells (LC50 values in the range of 12–20 μM) compared with ocellatin‐3N but was less hemolytic to mouse erythrocytes. However, the peptide showed no selectivity for tumor‐derived cells [LC50 = 20 μM for human umbilical vein endothelial cells (HUVECs)]. Ocellatin‐3N and [D4K]ocellatin‐3N stimulated the release of insulin from BRIN‐BD11 clonal β‐cells at concentrations ≥1 nM, and [A18K]ocellatin‐3N, at concentrations ≥0.1 nM. No peptide stimulated the release of lactate dehydrogenase at concentrations up to 3 μM, indicating that plasma membrane integrity had been preserved. The three peptides produced an increase in intracellular [Ca2+] in BRIN‐BD11 cells when incubated at a concentration of 1 μM. In view of its high insulinotropic potency and relatively low hemolytic activity, the [A18K] ocellatin analog may represent a template for the design of agents with therapeutic potential for the treatment of patients with type 2 diabetes.Keywords
This publication has 33 references indexed in Scilit:
- Analogues of the frog skin peptide alyteserin‐2a with enhanced antimicrobial activities against Gram‐negative bacteriaJournal of Peptide Science, 2012
- Structure, membrane orientation, mechanism, and function of pexiganan — A highly potent antimicrobial peptide designed from magaininBiochimica et Biophysica Acta (BBA) - Biomembranes, 2009
- Leptoglycin: A new Glycine/Leucine-rich antimicrobial peptide isolated from the skin secretion of the South American frog Leptodactylus pentadactylus (Leptodactylidae)Toxicon, 2009
- A proposed nomenclature for antimicrobial peptides from frogs of the genus LeptodactylusPeptides, 2008
- Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatmentExpert Opinion on Investigational Drugs, 2006
- Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2Regulatory Peptides, 2005
- Time-correlation between membrane depolarization and intracellular calcium in insulin secreting BRIN-BD11 cells: studies using FLIPRCell Calcium, 2004
- Optimization of Microbial Specificity in Cyclic Peptides by Modulation of Hydrophobicity within a Defined Structural FrameworkJournal of Biological Chemistry, 2002
- Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) miceDiabetologia, 1981
- Presence of Enteramine in the Skin of AmphibiaNature, 1951